Histamine H3 Receptor Agonist- and Antagonist-evoked Vacuous Chewing Movements in 6-ohda-lesioned Rats Occurs in an Absence of Change in Microdialysate Dopamine Levels.
From: Department of Pharmacology, Medical University of Silesia, H. Jordana 38, 41-808 Zabrze, Poland. pnowak@slam.katowice.pl
European journal of pharmacology
- Publish Date: Dec 2006
- ISSN: 0014-2999
- Volume: 552
- Issue: 1-3
- Pages: 46-54
- Medium: Print
- Language: English
- Citation (JAMA): Nowak Przemysław, Dabrowska Joanna, Bortel Aleksandra, et al. Histamine H3 Receptor Agonist- and Antagonist-evoked Vacuous Chewing Movements in 6-ohda-lesioned Rats Occurs in an Absence of Change in Microdialysate Dopamine Levels.. Eur. J. Pharmacol. Dec 2006;552:46-54
Abstract
In rats lesioned neonatally with 6-hydroxydopamine (6-OHDA), repeated treatment with SKF 38393 (1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol), a dopamine D(1)/D(5) receptor agonist, produces robust stereotyped and locomotor activities. The gradual induction of dopamine D(1) receptor supersensitivity is known as a priming phenomenon, and this process is thought to underlie not only the appearance of vacuous chewing movements in humans with tardive dyskinesia, but also the onset of motor dyskinesias in L-dihydroxyphenylalanine (L-DOPA)-treated Parkinson’s disease patients. The object of the present study was to determine the possible influence of the histaminergic system on dopamine D(1) agonist-induced activities. We found that neither imetit (5.0 mg/kg i.p.), a histamine H(3) receptor agonist, nor thioperamide (5.0 mg/kg i.p.), a histamine H(3) receptor antagonist/inverse agonist, altered the numbers of vacuous chewing movements in non-primed-lesioned rats. However, in dopamine D(1) agonist-primed rats, thioperamide alone produced a vacuous chewing movements response (i.e., P < 0.05 vs SKF 38393, 1.0 mg/kg i.p.), but did not modify the SKF 38393 effect. Notably, both imetit and thioperamide-induced catalepsy in both non-primed and primed 6-OHDA-lesioned rats, comparable in magnitude to the effect of the dopamine D(1)/D(5) receptor antagonist SCH 23390 (7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; 0.5 mg/kg i.p.). Furthermore, in primed animals both imetit and thioperamide intensified SCH 23390-evoked catalepsy. In vivo microdialysis established that neither imetit nor thioperamide altered extraneuronal levels of dopamine and its metabolites in the striatum of 6-OHDA-lesioned rats. On the basis of the present study, we believe that histaminergic systems may augment dyskinesias induced by dopamine receptor agonists, independent of direct actions on dopaminergic neurons.
Mesh Headings (Keywords): (R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Animals, Animals, Newborn, Catalepsy, Corpus Striatum, Dialysis Solutions, Dopamine, Histamine Agonists, Histamine Antagonists, Imidazoles, Male, Mastication, Microdialysis, Motor Activity, Oxidopamine, Piperidines, Rats, Rats, Wistar, Receptors, Histamine H3, Stereotyped Behavior, Thiourea
Check for Full Text / PubMed Unique Identifier (PMID): 17055481
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.